Navigation Links
New Research Reveals Need for Doctors to Know About Medical Tattoos
Date:4/21/2009

HOUSTON, April 21 /PRNewswire-USNewswire/ -- More people are turning to a new trend to let others know about their medical condition - tattooing. A case report will be presented Friday, May 15, at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress shedding light on this new phenomenon, while urging discussion from the medical community.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

One of the most obvious benefits of medical tattooing is for identification purposes in an emergency situation, especially for patients with diabetes, when a patient may be incapacitated - particularly in the case of hypoglycemic coma. However, it also poses some health concerns - ones that the study's primary author, Saleh Aldasouqi, MD, FACE, feels the medical community may need to weigh in on.

"Like it or not, tattooing for purposes of medical alerts is a phenomenon that is now occurring," Dr. Aldasouqi said. "It's imperative that the medical community take note and that, perhaps, appropriate regulation of the practice be proposed, especially for patients with diabetes."

Once that happens, Dr. Aldasouqi hopes that patients and their doctors can sit down, analyze the risks and benefits, and make an informed decision together.

Also at the 2009 AACE 18th Annual Meeting & Clinical Congress, diabetes experts will analyze the NICE-SUGAR study's impact on inpatient glycemic control. Other topics of interest include a look at the wide ranging impact of vitamin D in the human body, and clinical recommendations for the treatment of prediabetes - America's largest healthcare epidemic.

A short, one page bio and photo of Dr. Aldasouqi are available '/>"/>

SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument
2. Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors
3. New Research Shows Healthy Choice Lives Up To Its Name
4. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
5. Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells
6. USC researchers develop new drug to target tumor cells and blood vessels
7. Medarex Announces Clinical Data for MDX-1401 in Hodgkins Lymphoma at Annual Meeting of the American Association for Cancer Research
8. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
9. LSUHSC research shows fish oil protects against diseases like Parkinsons
10. Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research
11. Research Takes Aim at Pancreatic Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...tailing plastic surgery procedures is now availabl...dates can view procedures and print out informatio... (PRWEB) December 2, 2009 -- Recovery..., has always been dedicated to providing resources...es, providing liposuction garments, breast augment...
(Date:12/2/2009)...uthor James A. Feinstein, MD, has just released hi...s from Patients on Becoming a Doctor, that traces ...hool--the grueling clinical year. , ...009 -- Most people will, at some point or another,... gown or staring at someone else dressed in a tiny...
(Date:12/2/2009)...e-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: G...y Health Care Conference today at 2:30 p.m. Easter...t live and may be accessed through a link on the i...n-probe.com . The webcast will be available for 30... ,, Gen-Probe Incorporated is a global leader ...
(Date:12/2/2009)...wire/ -- LeapFrog Investments has announced a ZAR ...fe, the innovative South African insurer serving p... brings together LeapFrog, the leading microinsura...most innovative insurance businesses. The announce...fe has developed a distinctive and profitable busi...
(Date:12/2/2009)...cal trial presented today at the annual meeting of...provide the first strong evidence of the benefit o... breasts who are at elevated risk for breast cance...ghly sensitive in depicting early breast cancer. ,... in addition to mammography significantly improves...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2
...spital which is to be built on the site of Birming...gnal. The plans for this new ?600m super hospital .../. It is funded by a private finance initiative. ...ble. The Treasury has also approved the schem...
...ying a drive for better hygiene at rural levels, t... its threats against panchayat leaders who fail to...s. Last year the state assembly had amended th...lush in their homes within a year of being elected...
...ts have discovered that watching television for an...167 calories thereby adding over than six kilogram...ve discovered that watching television for an hour...n the first to put an exact figure has been put on...
...ead of the NHS, Sir Ian Carruthers, has proposed c...million NHS deficit//. He proposes to unveil h...ony Blair. Sir Ian believes the ?10.3 billion spen... they could benefit have arisen. NHS had been ...
...s syndrome, a common running ailment, can be treat...g to Dr. Ronald Adler, chief, Division of Ultrasou...be used to accurately diagnose the ailment and rel...ed by the back of the shoe consistently rubbing ag...
...who was convicted of murdering Lin Russell and her...he publication of a report that probes the failure...ling spree. // The independent report by Robert..., Josie and her father, Shaun wants the report to ...
Other Medicine News:Health News:Madhya Pradesh To Concentrate On Better Rural Hygiene 2Health News:Watching TV Blamed for Weight Gain 2Health News:Proper Diagnosis Could Augment Speedy Recovery Of Haglund’s Syndrom 2
(Date:12/1/2009)...., Dec. 1 CeloNova BioSciences, In... medical devices and of specialty implants, today ..., founder and medical director of Baptist Cardiac ...iscuss the CATANIA(TM) Stent System with NanoThin ...lar Interventions Conference to be held at the Hot...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
(Date:12/1/2009)...., Dec. 1 SCOLR Pharma, ... 20, 2009 it licensed to Chrono Nutraceuticals LLC...l four extended release dietary supplements using ...rm. In addition, SCOLR granted Chrono rights to m...ited States on a nonexclusive basis. Chrono paid ...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3American Nurses Association Joins the National Healthcare Career Network 54285 1American Nurses Association Joins the National Healthcare Career Network 54285 2American Nurses Association Joins the National Healthcare Career Network 54285 3Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 1Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 2Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 3The tourist trap 9540 1
...ial New Front-Line Treatment ...Genzyme Corp.,(Nasdaq: GENZ ) reported preliminar...2 study examining the safety and effectiveness of ...ously untreated, older adult,patients with acute m...fit,from conventional "7+3" anthracycline plus cyt...
...CALS, INC. (Nasdaq: VION ) today announced that i... lead anticancer agent Cloretazine(R),(VNP40101M) ...yelogenous,leukemia (AML) had been presented at th...linical Oncology (ASCO(R)) in Chicago, Illinois., ...atients. The median,age of these patients was 73 y...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 4
Fast-Cath™ Guiding Introducers
Lumenis 1000 Integrated Slit Lamp
Novus 30001
Selecta Trio Photocoagulator and SLT Combination Laser
Medicine Products: